More CDAK headlines

5 articles

Codiak BioSciences files for bankruptcy, looks to sell off assets

Codiak BioSciences' Engineered Exosome Candidates Show Early Antitumor Activity

Codiak BioSciences (CDAK) Stock: Why The Price Jumped Today

Codiak BioSciences' Exosome Candidate Shows Tumor Shrinkage In Early Study

CDAK Stock: Over 30% Increase Intraday Explanation

Explore More

Filter and sort all 500 stocks

Continuous multi-factor scoring & catalyst forensics

Today's biggest gainers and losers